Yang Xu

Yang Xu

Auto-generated profile, based on publicly available information

Yang Xu

Department of Hepatobiliary and Pancreatic Surgery, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 2019 in Stem Cell Research & Therapy
Verified
Journal Article
Open access
PDF file
YXYang Xu
Yang Xu
YHYan Huang
Yan Huang
YGYibing Guo
Yibing Guo
YXYicheng Xiong
Yicheng Xiong
SZShajun Zhu
Shajun Zhu
ZWZhiwei Wang
Zhiwei Wang
The regulatory mechanism of insulin-producing cells (IPCs) differentiation from induced pluripotent stem cells (iPSCs) in vitro is very important in the phylogenetics of pancreatic islets, the molecular pathogenesis of diabetes, and the acquisition of high-quality pancreatic β-cells derived from stem cells for cell therapy. miPSCs were induced for IPCs differentiation. miRNA microarray assays were performed by using total RNA from our iPCs-derived IPCs containing undifferentiated iPSCs and iPSCs-derived IPCSs at day 4, day 14, and day 21 during step 3 to screen the differentially expressed miRNAs (DEmiRNAs) related to IPCs differentiation, and putative target genes of DEmiRNAs were predicted by bioinformatics analysis. miR-690 was selected for further research, and MPCs were transfected by miR-690-agomir to confirm whether it was involved in the regulation of IPCs differentiation in iPSCs. Quantitative Real-Time PCR (qRT-PCR), Western blotting, and immunostaining assays were performed to examine the pancreatic function of IPCs at mRNA and protein level respectively. Flow cytometry and ELISA were performed to detect differentiation efficiency and insulin content and secretion from iPSCs-derived IPCs in response to stimulation at different concentration of glucose. The targeting of the 3′-untranslated region of Sox9 by miR-690 was examined by luciferase assay. We found that miR-690 was expressed dynamically during IPCs differentiation according to the miRNA array results and that overexpression of miR-690 significantly impaired the maturation and insulinogenesis of IPCs derived from iPSCs both in vitro and in vivo. Bioinformatic prediction and mechanistic analysis revealed that miR-690 plays a pivotal role during the differentiation of IPCs by directly targeting the transcription factor sex-determining region Y (SRY)-box9. Furthermore, downstream experiments indicated that miR-690 is likely to act as an inactivated regulator of the Wnt signaling pathway in this process. We discovered a previously unknown interaction between miR-690 and sox9 but also revealed a new regulatory signaling pathway of the miR-690/Sox9 axis during iPSCs-induced IPCs differentiation.

31 October 2022 in Biomaterials
Verified
Journal Article
Closed access
YHYan Huang
Yan Huang
YXYang Xu
Yang Xu
JZJiachen Zhu
Jiachen Zhu
JWJian Wan
Jian Wan
YXYicheng Xiong
Yicheng Xiong
YYYumin Yang
Yumin Yang

3 June 2024 in Annals of Biomedical Engineering
Verified
Journal Article
Closed access
PDF file
LWLin Wang
Lin Wang
JWJian Wan
Jian Wan
YXYang Xu
Yang Xu
YHYan Huang
Yan Huang
DWDongzhi Wang
Dongzhi Wang
QGQingsong Guo
Qingsong Guo

1 April 2026 in Bioactive Materials
Verified
Journal Article
Open access
JZJiaqi Zhu
Jiaqi Zhu
XZXiaoren Zhu
Xiaoren Zhu
WFWei Feng
Wei Feng
YJYi Jin
Yi Jin
XGXinqi Ge
Xinqi Ge
YHYan Huang
Yan Huang
The reduction of stemness and pluripotency during the prolonged culture of hiPSCs poses a significant challenge in regenerative medicine. This study identified LINC MIR503HG as a factor involved in maintaining hiPSCs stemness. Consequently, it developed a highly efficient delivery system based on ADSC-EVs, named MIR503HG-EVs, to optimize the culture strategy for hiPSCs. During the extended culture, MIR503HG-EV-treated hiPSCs developed into colonies with more compact morphology, an increased percentage of viable cells, as well as elevated OCT4, SOX2, and NANOG expression. Furthermore, these cells maintained their chromosomal integrity, as no karyotypic anomalies were detected. Mechanistic studies demonstrated that MIR503HG selectively bound AHCTF1 to facilitate the active nucleocytoplasmic transport of MYC mRNA. This resulted in significantly augmented MYC protein production, which activated the stemness regulatory network. Concurrently, MIR503HG-EVs mitigated the decline in differentiation potential of hiPSCs after several passages by modulating the chromatin accessibility of stemness transcription factors and modifying energy metabolism, including glycolysis and oxidative phosphorylation pathways. Moreover, treatment with MIR503HG-EVs significantly enhanced the differentiation efficiency of high-passage hiPSCs into definitive endoderm, pancreatic, and hepatic lineages, thereby achieving a level of proficiency comparable to that of low-passage clones. Overall, this study identified the addition of MIR503HG-EVs as a convenient, efficient, and safe approach for maintaining high-passage hiPSCs.